NASDAQ: LFCR

Lifecore Biomedical Inc.

Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Lifecore Biomedical, Inc. (NASDAQ: LFCR) between October 7, 2020 and March 19, 2024, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than September 27, 2024.

If you purchased Lifecore securities and would like to join the action, please click “Join This Class Action.”

集体诉讼期:October 7, 2020 through March 19, 2024
If you purchased Lifecore Biomedical securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
Contact Us

案件详情:

According to the lawsuit, during the Class Period, defendants made false and/or misleading statements and/or failed to disclose that:

  • Lifecore maintained deficient internal controls over financial reporting;
  • as a result, Lifecore issued several financial statements that were inaccurate and would need to be restated;
  • Lifecore’s purported remediation efforts with respect to the foregoing deficiencies were ineffective;
  • all of the foregoing impaired Lifecore’s ability to timely file periodic reports with the Securities and Exchange Commission in compliance with NASDAQ listing requirements;
  • accordingly, Lifecore’s financial position and/or prospects were materially overstated; and
  • as a result, Lifecore’s public statements were materially false and misleading at all relevant times.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Attorney Advertising. Prior results do not guarantee a similar outcome.

关注我们:

The Rosen Law Firm has been ranked among the top 4 law firms each year since 2013 for the number of successful securities class actions on behalf of investors. In 2019 alone, our firm recovered $438 million for investors.

投资者应仔细鉴别和遴选在引领证券集体诉讼方面有多年成功经验的的律师。通常,其他律所会发布关于集体诉讼的新闻稿,但却没有类似的经验或资源。

机构股东服务公司按 2017 年证券集体诉讼索赔数量,罗森律师事务所列为第一名。

The Rosen Law Firm represents investors throughout the globe. Our mission is to prosecute securities fraud class actions and protect shareholders’ rights.

Rosenlegal
滚动至顶部